Insight Molecular Diagnostics (IMDX) Inventory (2024 - 2026)

Insight Molecular Diagnostics has reported Inventory for 3 years, with the latest figure at $382000.0 in Q1 2026.

• Quarterly Inventory fell 16.78% year-over-year to $382000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $382000.0 (down 16.78% YoY) and the FY2025 annual result came in at $446000.0, up 8.78% from the prior year.
• Inventory declined to $382000.0 in Q1 2026 per IMDX's latest filing, from $446000.0 in the prior quarter.
• Over five years, Inventory peaked at $693000.0 in Q2 2025 and troughed at $232000.0 in Q3 2024.
• A 3-year average of $441857.1 and a median of $446000.0 in 2025 frame the typical range for Inventory.
• The sharpest annual moves came in 2025 and 2026: Inventory soared 103.02% in 2025, then fell 16.78% in 2026.
• Over 3 years, Inventory stood at $410000.0 in 2024, then gained by 8.78% to $446000.0 in 2025, then dropped by 14.35% to $382000.0 in 2026.
• According to Business Quant data, Inventory over the past three periods registered $382000.0, $446000.0, and $471000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.